
iPSCs-derived NK cells: A Promising Tool for CAR-NK Immunotherapy
Adoptive Cell Therapy (ACT) represents a promising approach for the treatment of cancer. It is a process in which immune cells such as T-cells

Adoptive Cell Therapy (ACT) represents a promising approach for the treatment of cancer. It is a process in which immune cells such as T-cells

Preclinical Animal Models for CAR-T Cell Therapy Chimeric antigen receptor (CAR)-T cell therapy is one of the leading immunotherapies in oncology. Although many clinical trials

Contact our Customer Care, Sales & Scientific Assistance

Consult and asked questions about our products & services

Documentation of Technical & Safety Data Sheet, Guides and more...